Clinical Trials Directory

Trials / Unknown

UnknownNCT05998733

The Impact of Coagulation Disorders on the Diagnosis and Prognosis of Sepsis

Characteristics of Coagulation in Patients With Sepsis and the Role of Coagulation Disorders in the Development of Disease: a Retrospective Single-center Clinical Study

Status
Unknown
Phase
Study type
Observational
Enrollment
552 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers

Summary

The study was a retrospective, single-center clinical study. From all patients admitted to the emergency ICU during the period of 2013.1.1-2019.12.31, the investigators screened all patients who met the criteria of 1) ≤7 days from symptom onset to enrollment; 2) patients who also met the criteria of the presence of clinical infections and Sequential Organ Failure Assessment (SOFA) score ≥2; and 3) met the exclusion criteria, and retrospectively collected coagulation indices of the patients before anticoagulation with or without the use of heparin or low molecular heparin, and recorded the worst values of coagulation function of patients before heparin were recorded, and the organ function, inflammatory response, immune indexes, and conversion rate of severe disease were observed, so as to investigate the role of conventional coagulation indexes (FDP, D-dimer) and thromboelastography in the early diagnosis of septicemia patients and to indicate the prognosis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEarly general coagulation function (5 items of coagulation) and thromboelastogram monitoring* Correlation analysis of sepsis severity with FDP and D-Dimer * Discussion on the critical value and area under the curve of FDP and D-Dimer in diagnosis of sepsis * Differences in age and sex of FDP and D-Dimer in diagnosis of sepsis * Effect of FDP and D-Dimer diagnosis of sepsis on severe conversion rate and all-cause mortality of patients * The difference of thromboelastogram in patients with sepsis of different severity * Thromboelastogram items (R time α Correlation between angle, k time, maximum blood clot strength and comprehensive coagulation index) and sepsis

Timeline

Start date
2022-06-01
Primary completion
2023-09-01
Completion
2024-06-01
First posted
2023-08-21
Last updated
2023-08-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05998733. Inclusion in this directory is not an endorsement.